Clinical Trial Update: Mechanistic Studies of Psilocybin in Headache Disorders [EARLY_Phase 1]

View source ↗

Summary

A mechanistic early-phase study evaluating psilocybin for migraine-related headache disorders is described, with the trial currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Yale University | Conditions: Migraine | EARLY_Phase 1 | Status: RECRUITING